MADEDDU, CLELIA
 Distribuzione geografica
Continente #
EU - Europa 210.909
NA - Nord America 13.396
AS - Asia 1.433
SA - Sud America 27
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 8
Totale 225.814
Nazione #
IT - Italia 207.271
US - Stati Uniti d'America 13.331
UA - Ucraina 1.243
CN - Cina 1.090
SE - Svezia 977
DE - Germania 390
GB - Regno Unito 370
FI - Finlandia 319
FR - Francia 117
VN - Vietnam 90
SG - Singapore 88
CA - Canada 61
IN - India 45
NL - Olanda 35
RU - Federazione Russa 34
BE - Belgio 32
IR - Iran 32
IE - Irlanda 30
ES - Italia 21
BR - Brasile 19
EU - Europa 19
KR - Corea 18
HK - Hong Kong 12
AT - Austria 11
ID - Indonesia 8
JP - Giappone 8
TR - Turchia 8
BG - Bulgaria 7
CH - Svizzera 7
CZ - Repubblica Ceca 7
PL - Polonia 7
RO - Romania 7
TH - Thailandia 7
AU - Australia 6
PH - Filippine 6
TW - Taiwan 6
AR - Argentina 5
EG - Egitto 5
GR - Grecia 5
DK - Danimarca 4
EE - Estonia 4
JO - Giordania 4
HU - Ungheria 3
PT - Portogallo 3
UG - Uganda 3
BO - Bolivia 2
CM - Camerun 2
HR - Croazia 2
KE - Kenya 2
MG - Madagascar 2
MU - Mauritius 2
MX - Messico 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
EC - Ecuador 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
ML - Mali 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
TM - Turkmenistan 1
Totale 225.814
Città #
Cagliari 206.419
Fairfield 1.831
Woodbridge 1.738
Houston 1.198
Chandler 1.106
Ann Arbor 816
Ashburn 810
Seattle 761
Nyköping 740
Wilmington 726
Jacksonville 707
Cambridge 595
Dearborn 393
Boardman 273
Nanjing 236
New York 236
Boston 194
Beijing 176
Helsinki 132
San Diego 127
Dong Ket 90
Milan 85
Shenyang 75
Shanghai 73
Nanchang 72
Redwood City 69
Changsha 59
Guangzhou 59
Menlo Park 57
Hebei 56
London 47
Verona 47
Rome 45
Toronto 39
Tianjin 38
Norwalk 34
Jinan 32
Brussels 30
Jiaxing 30
Mountain View 30
Pune 27
Zhengzhou 26
Orange 24
Sassari 24
Los Angeles 22
Phoenix 21
Auburn Hills 20
Ningbo 20
Singapore 19
Hangzhou 18
Hefei 18
Kunming 18
Atlanta 16
Dublin 15
Leawood 14
Washington 14
Saint Petersburg 13
San Mateo 11
Vienna 11
Augusta 10
Amsterdam 9
Indiana 9
San Francisco 9
Taizhou 9
Wuhan 9
Chicago 8
Redmond 8
Rio de Janeiro 8
Berlin 7
Borås 7
Marrùbiu 7
Monmouth Junction 7
Rockville 7
Salerno 7
Baltimore 6
Bangkok 6
Chiswick 6
Falls Church 6
Islington 6
Jakarta 6
Kilburn 6
Kyjov 6
Torino 6
Turin 6
Winston-Salem 6
Xian 6
Brandizzo 5
Cedar Knolls 5
Fuzhou 5
Nürnberg 5
Paris 5
Sofia 5
Tabriz 5
Amman 4
Costa Mesa 4
Halle 4
Hong Kong 4
Hounslow 4
Madrid 4
Millbury 4
Totale 220.888
Nome #
High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts 4.520
Energy expenditure in caving (dataset) 3.708
Energy expenditure in caving 3.602
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.565
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.348
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.253
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.215
null 3.029
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 2.949
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 2.889
Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation 2.838
Systemic therapy for the treatment of endometrial cancer 2.746
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.648
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.489
Antimicrobial sulfonamides inhibit Herpesvirus 8 latency by impairing the MDM2-p53 complex formation 2.412
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.327
Sulfonamide compounds inhibit latent Human Herpesvirus 8 replication by interfering with MDM2-p53 complex formation 2.322
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 2.239
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.233
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.156
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.137
Molecular-biology-driven treatment for metastatic colorectal cancer 2.068
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.055
The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience 2.053
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.041
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.022
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 1.991
null 1.987
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 1.931
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 1.889
Validation of the CAchexia SCOre (CASCO). Staging cancer patients: The use of miniCASCO as a simplified tool 1.887
The utility of fibrinogen level as a predictor of complications after laparoscopic gynecologic surgery: a prospective observational study 1.878
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 1.851
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 1.845
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 1.786
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 1.771
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.740
Advances in pharmacologic strategies for cancer cachexia 1.710
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.707
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.704
null 1.699
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.636
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.632
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.611
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.576
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.574
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.550
Successful laparoscopic management of a giant ovarian cyst 1.547
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.541
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.515
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.510
null 1.489
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.489
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.476
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia 1.468
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.461
Surprising results of a supportive integrated therapy in myelofibrosis 1.456
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.449
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.438
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.415
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.392
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects 1.391
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.386
null 1.362
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.300
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.294
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 1.286
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.241
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.197
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.196
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.178
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.169
Thyroid dysfunction and ultrasonography features in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Preliminary results from a prospective cohort study. 1.155
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.135
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.133
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.085
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.076
null 1.063
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.040
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.027
null 998
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate 983
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 981
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 963
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 949
null 944
null 936
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 835
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 773
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 773
null 768
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 763
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 762
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review 756
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 751
Current medications for cancer cachexia 740
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer 733
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 719
Blocking inflammation to improve immunotherapy of advanced cancer 710
null 709
Totale 167.725
Categoria #
all - tutte 284.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 284.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.997 0 0 0 0 0 0 0 0 0 0 1.041 956
2019/202044.137 2.502 1.375 356 870 15.579 11.304 6.037 1.437 902 875 845 2.055
2020/202162.316 1.834 2.174 2.419 15.705 12.848 7.729 5.543 4.151 1.638 3.273 3.049 1.953
2021/202212.848 1.247 908 736 864 1.195 882 775 801 1.102 1.069 1.424 1.845
2022/202322.782 1.877 2.743 2.323 1.897 1.712 2.355 1.312 2.030 1.545 1.642 2.178 1.168
2023/202420.585 1.672 1.004 933 1.643 2.391 4.609 3.354 1.678 1.162 1.720 419 0
Totale 226.536